Clinical Trials Directory

Trials / Completed

CompletedNCT06427434

Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Postnatal Low Back Pain

Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Low Back Pain in Postnatal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Not accepted

Summary

This study will be carried out to evaluate the effect of modified lumbar Sustained Natural Apophyseal Glide on low back pain in postnatal women.

Detailed description

In fact, up to 75% of women who suffer from pregnancy-related back pain may continue to have pain after giving birth. Women who experience LBP or pelvic girdle pain (PGP) at 3 months postpartum were found to be at higher risk for persistent or chronic LBP. Of these women, only 6% recover within 6-18 months after giving birth. A modified lumbar Sustained Natural Apophyseal Glide (SNAG) is an existing Mulligan mobilization technique performed with a combination of joint glide and physiological spinal movement. The glide can be applied to the spinous processes, facets, or unilaterally over the transverse processes while the patient performs the active exercise. Few studies have been concerned with the effects of modified "SNAGS" on the lumbar spine . So, this study will be done to investigate its effect on low back pain in postnatal women aiming to improve their function to accomplish their daily living activities and reduce the side effects of medical treatment.

Conditions

Interventions

TypeNameDescription
OTHERStrengthening and stretching exercises to the back and abdominal musclesStrengthening and stretching exercises to the back and abdominal muscles will be performed for 30 min, three times per week for 4 weeks.
OTHERModified Lumbar Sustained Natural Apophyseal GlideModified Sustained Natural Apophyseal Glide will be applied on the affected lumbar level for 30 sec three times per week for 4 weeks.

Timeline

Start date
2024-06-01
Primary completion
2024-12-15
Completion
2024-12-30
First posted
2024-05-23
Last updated
2025-05-30

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06427434. Inclusion in this directory is not an endorsement.